Search results (21)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer
8 May 2024
The new method could help people with new-onset diabetes at high-risk of developing pancreatic cancer to be identified more accurately so that they can be monitored.
New target identified for pancreatic cancer treatment
25 September 2023
Researchers at NDORMS have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
Cancer Science DPhil student named Oxford Sparks Ambassador
9 January 2023
Giampiero Valenzano - who is currently reading for a DPhil in Oncology - has been announced as a 2022/2023 Oxford Sparks Ambassador.
Pancreatic cancer could be diagnosed up to three years earlier
3 November 2022
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests. Weight loss and increasing blood glucose levels are early indicators of pancreatic cancer and could lead to a more timely diagnosis, helping to improve survival rates.
Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis
28 June 2022
Body mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.
Predicting early recurrence of pancreatic cancer
3 May 2022
Dr Daniel Hughes and colleagues identify NUDT15 as a potential biomarker for pancreatic cancer recurrence following surgery.
New study shows MRI-guided radiotherapy could double survival rates for people with inoperable pancreatic cancer
7 February 2022
A study in partnership with GenesisCare has found high dose ablative radiotherapy doubles the chance of living at least two years after diagnosis.
Groundbreaking Oxford research could lead to early diagnosis of pancreatic cancer
27 January 2022
New research into the onset of diabetes which could go on to help in the early diagnosis of pancreatic cancer is being led by scientists at the University of Oxford.
Identifying protein biomarkers for pancreatic cancer
26 January 2022
Dr Christiana Kartsonaki and colleagues from the China Kadoorie Biobank have identified several proteins in the blood that are associated with an increased risk of pancreatic cancer.
New symptoms identified to help doctors diagnose pancreatic cancer
8 November 2021
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms, in the largest study of its kind.
Pancreatic cancer early detection funds awarded to Oxford researchers
19 October 2021
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
Oxford success at the early detection sandpit on pancreatic cancer
22 April 2021
Professor Eric O’Neill and Dr Pui San Tan receive funding as part of teams applying novel approaches for the early detection of pancreatic cancer.
T-cell landscape mapping identifies new targets for pancreatic cancer immunotherapy
13 April 2021
Through analysis of T-cell populations, Oxford pancreatic researchers identify novel therapeutic opportunities in pancreatic cancer patients
Potential of DNA-based blood tests for detecting pancreatic cancer earlier
11 December 2020
Dr Shivan Sivakumar and colleagues evaluate the current progress and future potential in using genetic and epigenetic methods for detecting pancreatic cancer DNA in the blood.
SCALOP team discover new pancreatic cancer biomarker
27 November 2020
The SCALOP clinical trial team have uncovered a new therapeutic target for locally advanced pancreatic cancer. Read more about it and the next steps for the SCALOP-2 trial.
The search for pancreatic cancer biomarkers
23 November 2020
Nuffield Department of Population Health researchers are using the China Kadoorie Biobank to identify potential protein biomarkers in the blood that could be used to predict the presence or development of pancreatic cancer
What we can learn from cancer survivors
19 November 2020
Understanding how an individual survives cancer, and why they respond well to therapy, can be vital in identifying new therapeutic targets. A new project seeks to see why some advanced pancreatic cancer patients overcome the odds and respond positively to treatment.
Early stage ‘red flag’ symptoms for pancreatic cancer
17 November 2020
The ADEPTS study uses the QResearch database to better understand what ‘red flag’ symptoms may be associated with pancreatic cancer, in the hopes of promoting earlier diagnosis from primary care.
Detecting pancreatic cancer through blood tests
9 November 2020
The Song Lab recently developed an effective and accurate way of detecting cancer biomarkers in the blood. Now, they are looking at the application of TAPS technology in pancreatic cancer
Innovative drug delivery techniques show promise in clinical trials
2 November 2020
Dr Laura Spiers talks about the TarDox and PanDox trials, which are using novel drug delivery techniques to improve the uptake of chemotherapy drugs into pancreatic tumours and other cancers